04.03.2024 19:02:17

EQS-Adhoc: Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.

EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Personnel
Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.

04-March-2024 / 19:02 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure of inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

 

Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.

Sevenum, 4 March 2024. The Supervisory Board of Redcare Pharmacy today has agreed to the early departure request of the Managing Board members Stephan Weber (CCO) and Marc Fischer (CIO). This decision comes at an ideal time to transition leadership responsibilities approximately one year before the end of their regular terms of office. This succession plan had been carefully developed and is the result of an extensive evaluation and selection process.

Subject to appointment by the Annual General Meeting (AGM) on 17 April 2024, Dirk Brüse will succeed Stephan Weber and Lode Fastré will follow Marc Fischer.

Dirk Brüse has been with Redcare Pharmacy since 2017 and, as Executive Director for country management and marketing, is responsible, among other things, for the P&L of the DACH region and for retail media. Lode Fastré co-founded the online pharmacy Farmaline, which was acquired by Redcare Pharmacy in 2016 and which has established the company's international expansion. He has driven several technology initiatives and has a deep understanding of Redcare Pharmacy and its IT landscape.

Both Stephan Weber and Marc Fischer have agreed with the Supervisory Board to serve Redcare Pharmacy in an advisory capacity until October 2026, provided the relevant agenda item is approved by the Annual General Meeting.

 

 


Contact:
rikutis consulting
Thomas Schnorrenberg
Cel: +49 151 46 53 13 17
E-Mail: presse@shop-apotheke.com


End of Inside Information

04-March-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: investors@redcare-pharmacy.com
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1851025

 
End of Announcement EQS News Service

1851025  04-March-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1851025&application_name=news&site_id=smarthouse

Analysen zu Redcare Pharmacy (ex Shop Apotheke)mehr Analysen

28.11.24 Redcare Pharmacy Buy Jefferies & Company Inc.
12.11.24 Redcare Pharmacy Sell UBS AG
06.11.24 Redcare Pharmacy Buy Deutsche Bank AG
06.11.24 Redcare Pharmacy Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
06.11.24 Redcare Pharmacy Sell UBS AG
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Redcare Pharmacy (ex Shop Apotheke) 159,50 -0,25% Redcare Pharmacy (ex Shop Apotheke)